Etiology and pathogenesis of epithelial ovarian cancer

Disease Markers

Volumn 23, Issue 5-6, 2007, Pages 367-376

  Mok, Samuel C ^a,b   Kwong, Joseph ^a   Welch, William R ^a   Samimi, Goli ^c,d   Ozbun, Laurent ^c   Bonome, Tomas ^c   Birrer, Michael J ^c   Berkowitz, Ross S ^a,b   Wong, Kwong Kwok ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER HARVARD CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Division of Cancer Prevention   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Inflammation; Microenvironment; Ovarian cancer; Pathogenesis

Indexed keywords

CANCER RISK; DISEASE COURSE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; NONHUMAN; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 36448949851     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/474320     Document Type: Review

References (85)

1. American Cancer Society, I. American Cancer Society, Cancer Facts and Figures-2005. www.cancer.org/docroot/STT/stt_0.asp, 2005.
2. D.A. Bell and R.E. Scully, Clinical perspective on borderline tumors of the ovary, Current Topics in Obstetrics and Gynecology, Elsevier Science Publishing Co., Inc, 1991, 119-133.
3. S.F. Serov and R.E. Scullt, Histological typing of ovarian tumors (International Histological Classification of Tumors No. 9), Geneva: World Health Organization, 1993.
4. B.R. Rao and B.J. Slotman, Endocrine factors in common epithelial ovarian cancer, Endocr Rev 12 (1991), 14-26.
5. G. Tortolero-Luna and M.F. Mitchell, The epidemiology of ovarian cancer, J Cell Biochem Suppl 23 (1995), 200-207.
6. D.W. Cramer, W.R. Welch, R.E. Scully and C.A. Wojciechowski, Ovarian cancer and talc: a case-control study, Cancer 50 (1982), 372-376.
7. G. Kvale, I. Heuch, S. Nilssen and V. Beral, Reproductive factors and risk of ovarian cancer: a prospective study, Int J Cancer 42 (1988), 246-251.
8. A.S. Whittemore, R. Harris and J. Itnyre, Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group, Am J Epidemiol 136 (1992), 1184-1203.
9. M.F. Fathalla, Incessant ovulation-a factor in ovarian neoplasia? Lancet 2 (1971), 163.
10. J.T. Casagrande, E.W. Louie, M.C. Pike, S. Roy, R.K. Ross and B.E. Henderson, Incessant ovulation and ovarian cancer, Lancet 2 (1979), 170-173.
11. N. Auersperg, I.A. Maclaren and P.A. Kruk, Ovarian surface epithelium: autonomous production of connective tissue-type extracellular matrix, Biol Reprod 44 (1991), 717-724.
12. P.A. Cerutti, Prooxidant states and tumor promotion, Science 227 (1985), 375-381.
13. B.N. Ames and L.S. Gold, Carcinogenesis debate, Science 250 (1990), 1498-1499.
14. S.M. Cohen and L.B. Ellwein, Cell proliferation in carcinogenesis, Science 249 (1990), 1007-1011.
15. A.K. Godwin, J.R. Testa, L.M. Handel, Z. Liu, L.A. Vanderveer, P.A. Tracey and T.C. Hamilton, Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer, J Natl Cancer Inst 84 (1992), 592-601.
16. J.R. Testa, L.A. Getts, H. Salazar, Z. Liu, L.M. Handel, A.K. Godwin and T.C. Hamilton, Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity, Cancer Res 54 (1994), 2778-2784.
17. W.J. Murdoch, R.S. Townsend and A.C. McDonnel, Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/ survival and apoptosis, Biol Reprod 65 (2001), 1417-1424.
18. E.C. Brooks, N.N. Mahr, Z. Radisavljevic, E.D. Jacobson and L.S. Terada, Nitric oxide attenuates and xanthine oxidase exaggerates lung damage-induced gut injury, Am J Physiol 272 (1997), G845-852.
19. A. Blaustein, Surface cells and inclusion cysts in fetal ovaries, Gynecol Oncol 12 (1981), 222-233.
20. D.W. Cramer and W.R. Welch, Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis, J Natl Cancer Inst 71 (1983), 717-721.
21. R. Kulkarni and J.M. McGarry, Follicular stimulation and ovarian cancer, BMJ 299 (1989), 740.
22. G.L. Goldberg and C.D. Runowicz, Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation-is there a link? Am J Obstet Gynecol 166 (1992), 853-854.
23. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore and S.G. Self, Ovarian tumors in a cohort of infertile women, N Engl J Med 331 (1994), 771-776.
24. J. Blaakaer, H. Djursing, U. Hording, P. Bennett, K. Toftager-Larsen, J.E. Bock and P.E. Lebech, The pituitary-gonadal axis in women with benign or malignant ovarian tumors, Acta Endocrinol (Copenh) 127 (1992), 127-130.
25. D.W. Cramer, R.L. Barbieri, H. Xu and J.K. Reichardt, Determinants of basal follicle-stimulating hormone levels in premenopausal women, J Clin Endocrinol Metab 79 (1994), 1105-1109.
26. H.A. Risch, Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone, J Natl Cancer Inst 90 (1998), 1774-1786.
27. S.M. Ho, K.M. Lau, S.C. Mok and V. Syed, Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells, Oncogene 22 (2003), 4243-4256.
28. A. Lukanova and R. Kaaks, Endogenous hormones and ovarian cancer: epidemiology and current hypotheses, Cancer Epidemiol Biomarkers Prev 14 (2005), 98-107.
29. W.J. Murdoch and A.C. McDonnel, Roles of the ovarian surface epithelium in ovulation and carcinogenesis, Reproduction 123 (2002), 743-750.
30. C.E. Gargett, Stem cells in gynaecology, Aust N Z J Obstet Gynaecol 44 (2004), 380-386.
31. L. Dubeau, The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 72 (1999), 437-442.
32. D.W. Cramer, R.F. Liberman, L. Titus-Ernstoff, W.R. Welch, E.R. Greenberg, J.A. Baron and B.L. Harlow, Genital talc exposure and risk of ovarian cancer, Int J Cancer 81 (1999), 351-356.
33. A. Melin, P. Sparen, I. Persson and A. Bergqvist, Endometriosis and the risk of cancer with special emphasis on ovarian cancer, Hum Reprod 21 (2006), 1237-1242.
34. F. Parazzini, C. La Vecchia, E. Negri, S. Moroni, D. dal Pino and L. Fedele, Pelvic inflammatory disease and risk of ovarian cancer, Cancer Epidemiol Biomarkers Prev 5 (1996), 667-669.
35. K.A. Rosenblatt and N.B. Rosenshein, Mumps parotitis and ovarian cancer, Am J Obstet Gynecol 149 (1984), 472-474.
36. R.B. Ness and C. Cottreau, Possible role of ovarian epithelial inflammation in ovarian cancer, J Natl Cancer Inst 91 (1999), 1459-1467.
37. R.B. Ness, J.A. Grisso, C. Cottreau, J. Klapper, R. Vergona, J.E. Wheeler, M. Morgan and J.J. Schlesselman, Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer, Epidemiology 11 (2000), 111-117.
38. L.L. Espey, Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction, Biol Reprod 50 (1994), 233-238.
39. L.L. Espey, Ovulation as an inflammatory reaction-a hypothesis, Biol Reprod 22 (1980), 73-106.
40. N. Bonello, K. McKie, M. Jasper, L. Andrew, N. Ross, E. Braybon, M. Brannstrom and R.J. Norman, Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat, Biol Reprod 54 (1996), 436-445.
41. J.S. Richards, D.L. Russell, S. Ochsner and L.L. Espey, Ovulation: new dimensions and new regulators of the inflammatory-like response, Annu Rev Physiol 64 (2002), 69-92.
42. J.S. Fleming, C.R. Beaugie, I. Haviv, G. Chenevix-Trench and O.L. Tan, Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses, Mol Cell Endocrinol 247 (2006), 4-21.
43. J.M. Burke, D.J. Carroll, K.E. Rowe, W.W. Thatcher and F. Stormshak, Intravascular infusion of lipid into ewes stimulates production of progesterone and prostaglandin, Biol Reprod 55 (1996), 169-175.
44. M.A. Nash, G. Ferrandina, M. Gordinier, A. Loercher and R.S. Freedman, The role of cytokines in both the normal and malignant ovary, Endocr Relat Cancer 6 (1999), 93-107.
45. J. Wilson and F. Balkwill, The role of cytokines in the epithelial cancer microenvironment, Semin Cancer Biol 12 (2002), 113-120.
46. W.J. Murdoch, D.C. Colgin and J.A. Ellis, Role of tumor necrosis factor-alpha in the ovulatory mechanism of ewes, J Anim Sci 75 (1997), 1601-1605.
47. W.J. Murdoch, E.A. Van Kirk and J. Murdoch, Plasmin cleaves tumor necrosis factor alpha exodomain from sheep follicular endothelium: implication in the ovulatory process, Biol Reprod 60 (1999), 1166-1171.
48. W.L. Yang, A.K. Godwin and X.X. Xu, Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk, Cancer Res 64 (2004), 1534-1540.
49. D. Medina, Stromal fibroblasts influence human mammary epithelial cell morphogenesis, Proc Natl Acad Sci USA 101 (2004), 4723-4724.
50. M. Jinnin, H. Ihn, Y. Asano, K. Yamane, M. Trojanowska and K. Tamaki, Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1, Oncogene 23 (2004), 1656-1667.
51. H.A. Makhluf, J. Stepniakowska, S. Hoffman, E. Smith, E.C. LeRoy and M. Trojanowska, IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts, J Invest Dermatol 107 (1996), 856-859.
52. W.J. Rettig, H.P. Erickson, A.P. Albino and P. Garin-Chesa, Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways, J Cell Sci 107(Pt 2) (1994), 487-497.
53. Y. Nakamura, S. Esnault, T. Maeda, E.A. Kelly, J.S. Malter and N.N. Jarjour, Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts, J Immunol 172 (2004), 1945-1952.
54. S.S. McCachren and V. Lightner, A. Expression of human tenascin in synovitis and its regulation by interleukin-1, Arthritis Rheum 35 (1992), 1185-1196.
55. N. Thomasset, A. Lochter, C.J. Sympson, L.R. Lund, D.R. Williams, O. Behrendtsen, Z. Werb and M.J. Bissell, Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development, Am J Pathol 153 (1998), 457-467.
56. D.C. Radisky, D.D. Levy, L.E. Littlepage, H. Liu, C.M. Nelson, J.E. Fata, D. Leake, E.L. Godden, D.G. Albertson, M.A. Nieto, Z. Werb and M.J. Bissell, Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability, Nature 436 (2005), 123-127.
57. M. Arai, J. Utsunomiya and Y. Miki, Familial breast and ovarian cancers, Int J Clin Oncol 9 (2004), 270-282.
58. A.B. Spurdle, J.L. Hopper, X. Chen, G.S. Dite, M.R. McCredie, G.G. Giles, D.J. Venter, M.C. Southey, D.M. Purdie and G. Chenevix-Trench, The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women, Cancer Epidemiol Biomarkers Prev 10 (2001), 1287-1293.
59. S.W. Baxter, D.Y. Choong, D.M. Eccles and I.G. Campbell, Polymorphic variation in CYP19 and the risk of breast cancer, Carcinogenesis 22 (2001), 347-349.
60. E.I. Garner, E.E. Stokes, R.S. Berkowitz, S.C. Mok and D.W. Cramer, Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O- methyltransferase and risk of epithelial ovarian cancer, Cancer Res 62 (2002), 3058-3062.
61. X. Zhou, S.C. Mok, Z. Chen, Y. Li and D.T. Wong, Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array, Hum Genet 115 (2004), 327-330.
62. L.E. Puls, D.E. Powell, P.D. DePriest, H.H. Gallion, J.E. Hunter, R.J. Kryscio and J.R. van Nagell, Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma, Gynecol Oncol 47 (1992), 53-57.
63. R.E. Scully, D.A. Bell and G.M. Abu-Jawdeh, Update on early ovarian cancer and cancer developing in benign ovarian tumors, in: Ovarian Cancer 3, F. Sharp, P. Mason, T. Blackett and J. Berek, eds, London: Chapman & Hall Medical, 1992, pp. 139-144.
64. D.A. Bell and R.E. Scully, Early de novo ovarian carcinoma. A study of fourteen cases, Cancer 73 (1994), 1859-1864.
65. B.G. Tutschka and S.C. Lauchlan, Endosalpingiosis, Obstet Gynecol 55 (1980), 57S-60S.
66. R.E. Burmeister, R.E. Fechner and R.R. Franklin, Endosalpingiosis of the peritoneum, Obstet Gynecol 34 (1969), 310-318.
67. R. Schuldenfrei and N.A. Janovski, Disseminated endosalpingiosis associated with bilateral papillary serous cystadenocarcinoma of the ovaries, Am J Obstet Gynecol 84 (1962), 382.
68. T. Bonome, J.Y. Lee, D.C. Park, M. Radonovich, C. Pise-Masison, J. Brady, G.J. Gardner, K. Hao, W.H. Wong, J.C. Barrett, K.H. Lu, A.K. Sood, D.M. Gershenson, S.C. Mok and M.J. Birrer, Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary, Cancer Res 65 (2005), 10602-10612.
69. M. Shih Ie and R.J. Kurman, Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis, Am J Pathol 164 (2004), 1511-1518.
70. A. Malpica, M.T. Deavers, K. Lu, D.C. Bodurka, E.N. Atkinson, D.M. Gershenson and E.G. Silva, Grading ovarian serous carcinoma using a two-tier system, Am J Surg Pathol 28 (2004), 496-504.
71. S.C. Mok, D.A. Bell, R.C. Knapp, P.M. Fishbaugh, W.R. Welch, M.G. Muto, R.S. Berkowitz and S.W. Tsao, Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy, Cancer Res 53 (1993), 1489-1492.
72. M.I. Edelson, C.C. Lau, C.V. Colitti, W.R. Welch, D.A. Bell, R.S. Berkowitz and S.C. Mok, A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors, Oncogene 16 (1998), 197-202.
73. J. Tangir, N.S. Loughridge, R.S. Berkowitz, M.G. Muto, D.A. Bell, W.R. Welch and S.C. Mok, Frequent microsatellite instability in epithelial borderline ovarian tumors, Cancer Res 56 (1996), 2501-2505.
74. C.V. Colitti, K.J. Rodabaugh, W.R. Welch, R.S. Berkowitz and S.C. Mok, Anovel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas, Oncogene 16 (1998), 555-559.
75. M.I. Edelson, S.W. Scherer, L.C. Tsui, W.R. Welch, D.A. Bell, R.S. Berkowitz and S.C. Mok, Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas, Oncogene 14 (1997), 2979-2984.
76. L.W. Huang, A.P. Garrett, J.O. Schorge, M.G. Muto, D.A. Bell, W.R. Welch, R.S. Berkowitz and S.C. Mok, Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum, Am J Clin Pathol 114 (2000), 93-99.
77. K.H. Lu, J.N. Weitzel, S. Kodali, W.R. Welch, R.S. Berkowitz and S.C. Mok, A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmuci nous epithelial ovarian carcinomas, Cancer Res 57 (1997), 387-390.
78. I. Wertheim, J. Tangir, M.G. Muto, W.R. Welch, R.S. Berkowitz, W.Y. Chen and S.C. Mok, Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors, Oncogene 12 (1996), 2147-2153.
79. J. Tangir, M.G. Muto, R.S. Berkowitz, W.R. Welch, D.A. Bell and S.C. Mok, A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer, Oncogene 12 (1996), 735-740.
80. P. Russell, The pathological assessment of ovarian neoplasms. I: Introduction to the common 'epithelial' tumours and analysis of benign 'epithelial' tumours, Pathology 11 (1979), 5-26.
81. I.G. Campbell, S. Morland and A. Hitchcock, Endometriosis and the relationship with ovarian cancer, in: Ovarian Cancer 5, F. Sharp, T. Blackett, J. Derek and R. Bast, eds, Oxford: ISIS Medical Media Ltd., 1998, pp. 159-170.
82. X. Jiang, S.J. Morland, A. Hitchcock, E.J. Thomas and I.G. Campbell, Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage, Cancer Res 58 (1998), 1707-1712.
83. K. Obata, S.J. Morland, R.H. Watson, A. Hitchcock, G. Chenevix-Trench, E.J. Thomas and I.G. Campbell, Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors, Cancer Res 58 (1998), 2095-2097.
84. Y. Hashiguchi, H. Tsuda, T. Inoue, R.S. Berkowitz and S.C. Mok, PTEN expression in clear cell adenocarcinoma of the ovary, Gynecol Oncol 101 (2006), 71-75.
85. D.M. Dinulescu, T.A. Ince, B.J. Quade, S.A. Shafer, D. Crowley and T. Jacks, Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer, Nat Med 11 (2005), 63-70.